|
Aprikyan, A.A.G., Kutyavin, T., Stein, S., Aprikian, P., Rodger, E., Liles, W.C., Boxer, L.A., Dale, D.C. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exper Hematol. 2003. 31:372-381.
Brooks-Worrell, B.M., Greenbaum, C.J., Palmer, J.P., Pihoker, C. Autoimmunity to islet proteins in children diagnosed with new-onset diabetes. J Clin Endocrinol Metab. 2004. 89:2222-2227.
Brown, A.J.L., Frost, S.D.W., Good B., Daar, E.S., Simon, V., Markowitz, M., Collier, A.C., Connick, E., Conway, B., Margolick, J.B., Routy, J-P., Corbeil, J., Hellmann, N.S., Richman, D.D., Little, S.J. Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacvity of human immunodeficiency virus type 1 strains in primary infection. J Virology. 2004. 78(5):2242-2246.
Callahan, H.S., Cummings, D.E., Pepe, M.S., Breen, P.A., Matthys, C.C., Weigle, D.S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans. J Clin Endocrinol Metab. 2004. 89(3):1319-1324.
Carr, M.C., Ayyobi, A.F., Murdoch, S.J., Deeb, S.S., Brunzell, J.D. Contribution of hepatic lipase, lipoprotein lipase, and cholesteryl ester transfer protein to LDL and HDL heterogeneity in healthy women . Arterio Thromb Vasc Biol. 2002. 22(4):667-673.
Carr, M.C., Brunzell, J.D., Deeb, S.S. Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: Role of central obesity and LIPC polymorphisms. J Lipid Res. 2004. 45:466-473.
Cheung, M.C., Sibley, S.D., Palmer, J.P., Oram, J.F., Brunzell, J.D. Lipoprotein lipase and hepatic lipase: Their relationship with HDL subspecies (Lp(A-1) and Lp(A-I,A-II). J Lipid Res. 2003. 44:1552-1558.
Cnop, M., Havel, P.J., Utzschneider, K.M., Carr, D.B., Sinha, M.K., Boyko, E.J., Retzlaff, B.M., Knopp, R.H., Brunzell, J.D., Kahn, S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: Evidence for independent roles of age and sex. Diabetologia. 2003. 46:459-469.
Cnop, M., Landchild, M.J., Vidal, J., Havel, P.J., Knowles, N.G., Carr, D.R., Wang, F., Hull, R.L., Boyko, E.J., Retzlaff, B.M., Walden, C.E., Knopp, R.H., Kahn, S.E. The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: Distinct metabolic effects of two fat compartments. Diabetes. 2002. 51:1005-1015.
Dale, D.C., Cottle, T.E., Fier, C.J., Bolyard, A.A., Bonilla, M.A., Boxer, L.A., Cham, B., Freedman, M.H., Kannourakis, G., Kinsey, S.E., Davis, R., Scarlata, D., Schwinzer, B., Zeidler, C., Welte, K. Severe chronic neutropenia: Treatment and follow-up of patients in the severe chronic neutropenia international registry. Am J Hematol. 2003. 72:82-93.
Dale, O., Hoffer, C., Sheffels, P., Kharasch, E.D. Disposition of nasal, intravenous, and oral methadone in healthy volunteers. Clin Pharmacol Ther. 2002. 72:536-545.
Deeb, S.S., Zambon, A., Carr, M.C., Ayyobi, A.F., Brunzell, J.D. Hepatic lipase and dyslipidemia: Interactions among genetic variants, obesity, gender, and diet. J Lipid Res. 2003. 44:1279-1286.
Diabetes Control and Complications Trial/Epedemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 Diabetes mellitus on development and progression of diabetic nephropathy: The epidemiology of diabetes interventions and complications (EDIC) study. JAMA. 2003. 290(16):2159-2167.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Intensive diabetes therapy and carotid intima-Media thickness in type 1 Diabetes mellitus . N Engl J Med. 2003. 348:2294-2303.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes. Diabetes Care. 2003. 26(5):1439-1448.
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort. Diabetes Care. 2003. 26(3):810-818.
DiCenzo, R., Forrest, A., Fischl, M.A., Collier, A., Feinberg, J., Ribaudo, H., DiFrancecso, R., Morse, G.D., AIDS Clinical Trials Group 388/733/5060 Study Team. Pharmacokinetics of indinavir and nelfinavir in treatment-naive, human immunodeficiency virus-infected subjects. Antimicrobial Agents Chemotherapy. 2004. 48(3):918-923.
Diem, P., Laederach-Hofmann, K., Navarro, X., Mueller, B., Kennedy, W.R., Robertson, R.P. Diagnosis of diabetic autonomic neuropathy: A multivariate approach. Eur J Clin Invest. 2003. 33(8):693-697.
Disis, M.L., Goodell, V., Schiffman, K., Knutson, K.L. Humoral epitope spreading following immunication with a HER-2/neu peptide based vaccine in cancer patients. In Press. 2004. Accepted 2/1/2004.
Disis, M.L., Schiffman, K., Guthrie, K., Salazar, L.G., Knutson, K.L., Goodell, V., dela Rosa, C., Cheever, M.A. Effect of dose on immune response in patients vaccinated with a HER-2/neu intracellular domain protein based vaccine. In Press. 2004. Accepted 1/1/2004.
Emery, M.G., Fisher, J.M., Chien, J.Y., Kharasch, E.D., Dellinger, E.P., Kowdley, K.V., Thummel, K.E. CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology. 2003. 38:428-435.
Ensinck, J.W., Laschansky, E.C., Vogel, R.E., D'Alessio, D.A. Effect of ingested nutrients on the release of thrittene into the human circulation. J Clin Endocrinol Metab. 2003. 88:4798-4804.
Fischl, M.A., Ribaudo, H.J., Collier, A.C., Giuliano, E.A., Dehlinger, M., Eron, J.J., Jr., Saag, M.S., Hammer, S.M., Vella, S., Morse, G.D., Feinberg, J.E., Denter, L.M., Eshleman, S.H., Adult Aids Clinical Trials Group 388 study team. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodificiency virus disease. J Infect Dis. 2003. 188(5):625-634.
Grant, G.A., Britz, G.W., Goodkin, R., Jarvik, J.G., Maravilla, K., Kliot, M. The utility of magnetic resonance imaging in evaluating peripheral nerve disorders. Muscle Nerve. 2002. 25(3):314-331.
Greenbaum, C., Seidel, K., Pihoker, C. The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes. Diabetes Care. 2004. 27(5):1202-1204.
Greenbaum, C.J., Harrison, L.C., Immunology of Diabetes Society. Perspectives in Diabetes: Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes. Diabetes. 2003. 52:1059-1065.
Hayashi, T., Boyko, E.J., Leonetti, D.L., McNeely, M.J., Newell-Morris, L., Kahn, S.E., Fujimoto, W.Y. Visceral adiposity and the prevalence of hypertension in Japanese Americans. Circulation. 2003. 108:1718-1723.
Hebert, M.F., Park, J.M., Chen, Y-L., Akhtar, S., Larson, A.M. Effects of St. John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol. 2004. 44:89-94.
Herbst, K.L., Tannock, L.R., Deeb, S.S., Purnell, J.Q., Brunzell, J.D., Chait, A. Kobberling type of familial partial lipodystrophy: An underrecognized syndrome. Diabetes Care. 2003. 26:1819-1824.
Ho, W.Y., Blattman, J.N., Dossett, M.L., Yee, C., Greenberg, P.D. Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell. 2003. 3:431-437.
Ibrahim, A.E., Feldman, J., Karim, A., Kharasch, E.D. Simultaneous assessment of drug interations with low- and high-extraction opioids: Application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil. Anesthesiology. 2003. 98(4):853-861.
Irwin, M.L., Yasui, Y., Ulrich, C.M., Bowen, D., Rudolph, R.E., Schwartz, R.S., Yukawa, M., Aiello, E., Potter, J.D., McTiernan, A. Effect of exercise on total and intra-abdominal body fat in postmenopausal women: A randomized controlled trial. JAMA. 2003. 289(3):323-330.
Jarvik, J.G., Yuen, E., Haynor, D.R., Bradley, C.M., Fulton-Kehoe, D., Smith-Weller, T., Wu, R., Kliot, M., Kraft G., Wang, L., Erlich, V., Heagerty, P.J., Franklin, G.M. MR nerve imaging in a prospective cohort of patients with suspected carpal tunnel syndrome. Neurology. 2002. 58(11):1583-1584.
Jenkins, A.J., Lyons, T.J., Zheng, D., Otvos, J.D., Lackland, D.T., McGee, D., Garvey, W.T., Klein, R.L., Diabetes Control and Complications Trial/Epedemiology of Diabetes Interventions and Complications Research Group. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: Associations with gender and glycemia. Diabetes Care. 2003. 26:810-818.
Jenkins, A.J., Lyons, T.J., Zheng, D., Otvos, J.D., Lackland, D.T., McGee, D., Garvey W.T., Klein, R.L., Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy. Kidney International. 2003. 64:817-828.
Kahn, S.E. Review: The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia. 2003. 46:3-19.
Kharasch, E.D., Hoffer, C., Whittington, D., Sheffels, P. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine. Clin Pharmacol Ther. 2003. 74:543-554.
Klein, R.L., Hunter, S.J., Jenkins, A.J., Zheng, D., Semler, A.J., Clore, J., Garvey, W.T., Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care. 2003. 26:1439-1448.
Knopp, R.H., Retzlaff, B., Aikawa, K., Kahn, S.E. Management of patients with diabetic hyperlipidemia. Am J Cardiol. 2003. 91:24E-28E.
Knopp, R.H., Retzlaff, B., Fish, B., Walden, C., Wallick, S., Anderson, M., Aikawa, K., Kahn, S.E. Effects of insulin resistance and obesity on lipoproteins and sensitivity to egg feeding. Arterio Thromb Vasc Biol. 2003. 23(8):1437-1443.
Knowles, N.G., Landchild, M.A., Fujimoto, W.Y., Kahn, S.E. Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes. Diabetes Care. 2002. 25:292-297.
Krischer, J.P., Cuthbertson, D.D., Yu, L., Orban, T., Maclaren, N., Jackson, R., Winter, W.E., Schatz, D.A., Palmer, J.P., Eisenbarth, G.S., Diabetes Prevention Trial-Type 1 Study Group. Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes. J Clin Endocrinol Metab. 2003. 88:103-108.
Liles, W.C., Broxmeyer, H.E., Rodger, E., Wood, B., Hubel, K., Cooper, S., Hangoc, G., Bridger, G.J., Henson, G.W., Calandra, G., Dale, D.C. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003. 102(8):2728-2730.
Lyons, T.J., Jenkins, A.J., Zheng, D., Lackland, D.T., McGee, D., Garvey, W.T., Klein, R.L., Diabetes Control and Complications Trial/Epedemiology of Diabetes Interventions and Complications Research Group. Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci. 2004. 45:910-918.
Mackey, M.D., Aprikyan, A.A.G., Dale, D.C. The rate of apoptosis in post mitotic neutrophil precursors of normal and neutropenic humans. Cell Prolif. 2003. 36:27-34.
McIlroy, D.R., Kharasch, E.D. Acute intravascular volume expansion with rapidly administered crystalloid or colloid in the setting of moderate hypovolemia. Anesth Analg. 2003. 96:1572-1577.
McNeel, D.G., Knutson, K.L., Schiffman, K., Davis, D.R., Caron, D., Disis, M.L. Pilot study of an HLA-A2 peptide vaccine using flt3 ligand as a systemic vaccine adjuvant. J Clin Immunol. 2003. 23:62-72.
Merriam, G.R., Schwartz, R.S., Vitiello, M.V. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endocrine. 2003. 22(1):1-8.
Moe, K.E. Hot flashes and sleep in women. Sleep Med Rev. 2004. Accepted 2/12/2004.
Moss, R.B., Rodman, D., Spencer, L.T., Aitken, M.L., Zeitlin, P.L., Waltz, D., Milla, C., Brody, A.S., Clancy, J.P., Ramsey, B., Hamblett, N., Heald, A.E. Repeated Adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest. 2004. 125:509-521.
Murdoch, S.J., Carr, M.C., Kennedy, H., Brunzell, J.D., Albers, J.J. Selective and independent associations of phospholipid transfer protein and hepatic lipase with the LDL subfraction distribution. J Lipid Res. 2002. 43(8):1256-1263.
Murdoch, S.J., Kahn, S.E., Albers, J.J., Brunzell, J.D., Purnell, J.Q. PLTP activity decreases with weight loss: Changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity. J Lipid Res. 2003. 44:1705-1712.
Naik, R.G., Lernmark, A., Palmer, J.P. Pathophysiology and genetics of type (insulin-dependent) diabetes. In: Diabetes Mellitus: Theory and Practice, 6th Edition (Porte Jr. D., Sherwin, R., Baron, A.D., eds); McGraw-Hill, New York. . 2004. :301-329.
Nieves, D.J., Cnop, M., Retzlaff, B., Walden, C.E., Brunzell, J.D., Knopp, R.H., Kahn, S.E. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes. 2003. 52:172-179.
O'Brien, K.D., Zhao, X-Q., Shavelle, D.M., Caulfield, M.T., Letterer, R.A., Kapadia, S.R., Probstfield, J.L., Otto, C.M. Hemodynamic effects of the angiotensin converting enzyme inhibitor, ramipril, in patients with mild-to-moderate aortic stenosis and preserved left ventricular function. In press. 2004. Accepted 2/1/2004.
Ordonez, C.L., Henig, N.R., Mayer-Hamblett, N., Accurso, F.J., Burns, J.L., Chmiel, J.F., Daines, C.L., Gibosn, R.L., McNamara, S., Retsch-Bogart, G.Z., Zeitlin, P.L., Aitken, M.L. Inflammatory and microbiologic markers in inducd sputum after intravenous antibiotics in cystic fibrosis. Am J Respir Crit Care Med. 2003. 168(12):1471-1475.
Palmer, J.P., Fleming, G.A., Greenbaum, C.J., Herold, K.C., Jansa, L.D., Kolb, H., Lachin, J.M., Polonsky, K.S., Skyler, J.S., Steffes, M.W. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function - Report of an ADA workshop, 21-22 October 2001. Diabetes. 2004. 53:250-264.
Park, J.M., Lin, Y.S., Calamia, J.C., Thummel, K.E., Slattery, J.T., Kalhorn, T.F., Carithers, R.L., Levy, A.E., Marsh, C.L., Hebert, M.F. Transiently altered acetaminophen metabolism after liver transplantation. Clin Pharmacol Ther. 2003. 73:545-553.
Paty, B.W., Ryan, E.A., Shapiro, A.M.J., Lakey, J.R.T., Robertson, R.P. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes. 2002. 51:3428-3434.
Pierce, C.H., Chen, Y.L., Dills, R.L., Morgan, M.S., Kalman, D.A. Toluene metabolites as biological indicators of exposure. Tox Lett. 2002. 129(1-2):65-76.
Pierce, C.H., Chen, Y.L., Hurtle, W., Morgan, M.S. Exponential modeling, washout curve reconstruction, and estimation of half-life of toluene and its metabolites. J Toxicol Environ Health. 2004. In press:.
Prigeon, R.L., Quddusi, S., Paty, B., D'Alessio, D.A. Suppression of glucose production by GLP-1 independent of islet hormones: A novel extrapancreatic effect. Am J Physiol Endocrinol Metab. 2003. 285:E701-E707.
Purnell, J.Q., Dev, R.K., Steffes, M.W., Cleary, P.A., Palmer, J.P., Hirsch, I.B., Hokanson, J.E., Brunzell, J.D. Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the diabetes control and complications trial. Diabetes. 2003. 52(10):2623-2629.
Purnell, J.Q., Weigle, D.S., Breen, P., Cummings, D.E. Ghrelin levels correlate with insulin levels, insulin resistance, and high-density lipoprotein cholesterol, but not with gender, menopausal status, or cortisol levels in humans. J Clin Endocrinol Metab. 2003. 88(12):5747-5752.
Quddusi, S., Vahl, T.P., Hanson, K., Prigeon, R.L., D-Alessioi, D.A. Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans. Diabetes Care. 2003. 26:791-798.
Robertson, R.P. Consequences of beta-cell function and reserve after long-term pancreas transplantation. Diabetes. 2004. 53:633-644.
Robertson, R.P. Editorial: Intrahepatically transplanted islets: Strangers in a strange land. J Clin Endocrin Mebab. 2002. 87(12):5416-5417.
Robertson, R.P. Review: Islet Transplantation as a treatment for diabetes - A work in progress. N Engl J Med. 2004. 350(7):694-705.
Robertson, R.P., Harmon, J., Tanaka, Y., Tran, P.O., Poitout, V. Glucose toxicity of the beta-cell: Cellular and molecular mechanisms. Diabetes Mellitus; LeRoith, Olefsky, Taylor (eds); Lippincott Williams Wilkins. 2002. 2nd Edition:129-139.
Robertson, R.P., Harmon, J., Tran, P.O., Tanaka, Y., Takahashi, H. Perspectives in Diabetes: Glucose toxicity in beta-cells: Type 2 diabetes, good radicals gone bad, and the glutathione connection. Diabetes. 2003. 52:581-587.
Robertson, R.P., Harmon, J., Tran, P.O.T., Poitout, V. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes. 2004. 53:S119-S124.
Robertson, R.P., Kendall, D.M. Islet transplantation 2003: Questions about its future. Curr Opin Endocrinol Diabetes. 2003. 10:128-132.
Robertson, R.P., Lanz, K.J., Sutherland, D.E.R., Seaquist, E.R. Relationship between diabetes and obesity 9 to 18 years after hemipancreatectomy and transplantation in donors and recipients. Transplantation. 2002. 73(5):736-741.
Robertson, R.P., Sutherland, D.E.R., Seaquist, E.R., Lanz, K.J. Glucagon, catecholamine, and symptom responses to hypoglycemia in living donors of pancreas segments. Diabetes. 2003. 52:1689-1694.
Salazar, L.G., Files, J., Southwood, S., Ishioka, G., Knutson, K.L., Gooley, T.A., Schiffman, K., Disis, M.L. Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles. Clin Cancer Res. 2003. 9:5559-5565.
Schacker, T., Zeh, J., Hu, H., Shaughnessy, M., Corey, L. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. J Infect Dis. 2002. 186:1718-1725.
Sibley, S.D., Palmer, J.P., Hirsch, I.B., Brunzell, J.D. Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes. J Clin Endocrinol Metab. 2003. 88(7):3379-3384.
Tworoger, S.S., Yasui, Y., Vitiello, M.V., Schwartz, R.S., Ulrich, C.M., Aiello, E.J., Irwin, M.L., Bowen, D., Potter, J.D., McTiernan, A. Effects of a yearlong moderate-intensity exercise and a stretching intervention on sleep quality in postmenopausal women. Sleep. 2003. 26(7):830-836.
Vitiello, M.V., Larsen, L.H., Moe, K.E. Age-related sleep change: Gender and estrogen effects on the subjective-objective sleep quality relationships of healthy, noncomplaining older men and women. J Psychosomatic Res. 2004. In press:.
Vitiello, M.V., Moe, K.E., Larsen, L.H., Merriam, G.R., Schwartz, R.S. Long-term growth hormone releasing hormone administration does not improve the sleep quality of healthy older men and women. Sleep. 2003. 26:A154.
Weigle, D.S., Cummings, D.E., Newby, P.D., Breen, P.A., Frayo, R.S., Matthys, C.C., Callahan, H.S., Purnell, J.Q. Roles of leptin and ghrelin in the loss of body weight caused by a low fat, high carbohydrate diet. J Clin Endocrinol Metab. 2003. 88(4):1577-1586.
Wilkin, T., Ludvigsson, J., Greenbaum, C., Palmer, J., Becker, D., Bruining, J. Future intervention trials in type 1 diabetes. Diabetes Care. 2004. 27(4):996-997.
Yee, C. Adoptive T cell therapy - immune monitoring and MHC multimers. Clin Immunol. 2003. 106:5-9.
Yee, C., Greenberg, P.D. Modulating T-cell immunity to tumors: New strategies for monitoring T-cell responses. Nat Rev Cancer. 2002. 2:409-419.
Yee, C., Thompson, J.A., Byrd, D., Riddell, S.R., Roche, P., Celis, E., Greenberg, P.D. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells. Immunology. 2002. 99(25):16168-16173.
Zambon, A., Deeb, S.S., Pauletto, P., Crepaldi, G., Brunzell, J.D. Hepatic lipase: A marker for cardiovascular disease risk and response to therapy. Curr Opin Lipidol. 2003. 14:179-189.
Zhao, X-Q., Morse, J.S., Dowdy, A.A., Heise, N., DeAngelis, D., Frohlich, J., Chait, A., Albers, J.J., Brown, B.G. Safety and tolerability of simvastatin plus niacin in patients with coronary artery disease and low high-density lipoprotein cholesterol (The HDL Atherosclerosis treatment study). Am J Cardiol. 2004. 93(3):307-312.
|